Bleeding Disorder Recruiting Phase 3 Trials for Fibrinogen human (DB09222)

IndicationStatusPhase
DBCOND0042114 (Bleeding Disorder)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03444324Adjusted Fibrinogen Replacement StrategyTreatment